2026-2030年全球特種酵素市場

全球特種酵素市場預計在 2025 年至 2030 年間成長至 26.912 億美元，預測期內複合年成長率為 7.5%。

本報告對全球特種酵素市場進行了全面分析，包括市場規模和預測、趨勢、成長促進因素、挑戰以及對約 25 家公司的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括精準醫療和先進治療方法的擴展、人工智慧 (AI) 在酶工程領域的應用，以及永續生產和潔淨標示舉措的興起。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告還包含歷史數據和預測數據。

本研究指出，未來幾年，基於酵素的精準診斷和個人化醫療將成為全球特種酵素市場成長的主要驅動力之一。此外，透過生成式人工智慧進行酵素發現的創新以及向高價值生命科學領域進行策略性產品組合重組，預計也將產生顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 對價格回應、生命週期、顧客購買籃、採用率和購買標準的分析。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球特種酵素市場
• 基於應用領域的細分市場分析，2020-2024 年
• 按類型分類的細分市場分析，2020-2024 年
• 基於來源的細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球特種酵素市場
• 地緣政治衝突的影響：全球特種酵素市場

第7章：五力分析

第8章 市場區隔：依應用領域

• 比較：透過應用
• 研究與生物技術
• 診斷
• 其他
• 市場機會：依應用領域分類

第9章 市場細分：依類型

• 比較：按類型
• 碳水化合物消化酶
• 蛋白酶
• 其他
• 市場機會：按類型分類

第10章 市場區隔：依來源

• 比較：按來源
• 微生物
• 植物
• 動物
• 市場機會：依來源分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
• 中東和非洲
  • 沙烏地阿拉伯
  • UAE
  • 南非
  • 以色列
  • 土耳其
• 南美洲
  • 巴西
  • 阿根廷
  • 智利
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Advanced Enzyme Technologies
• Amano Enzyme Inc.
• Amicogen Co. Ltd.
• BASF SE
• BBI Solutions OEM Ltd.
• Creative Enzymes
• DSM Firmenich AG
• F. Hoffmann La Roche Ltd.
• International Flavors Inc.
• Kerry Group Plc
• Maravai LifeSciences Holdings
• Nagase and Co. Ltd.
• Novonesis Group
• Sanofi SA
• Takara Bio Inc.

第16章附錄

The global specialty enzymes market is forecasted to grow by USD 2691.2 mn during 2025-2030, accelerating at a CAGR of 7.5% during the forecast period. The report on the global specialty enzymes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of precision medicine and advanced therapeutic modalities, increasing integration of artificial intelligence in enzyme engineering, rise of sustainable manufacturing and clean-label initiatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global specialty enzymes market is segmented as below:

By Application

• Research and biotechnology
• Diagnostic
• Others

By Type

• Carbohydrases
• Proteases
• Others

By Source

• Microorganisms
• Plants
• Animal

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• South America
  • Brazil
  • Argentina
  • Chile
• Rest of World (ROW)

This study identifies the shift toward enzyme-based precision diagnostics and personalized medicine as one of the prime reasons driving the global specialty enzymes market growth during the next few years. Also, revolutionization of enzyme discovery via generative artificial intelligence and strategic portfolio realignment toward high-value life science segments will lead to sizable demand in the market.

The report on the global specialty enzymes market covers the following areas:

• Global specialty enzymes market sizing
• Global specialty enzymes market forecast
• Global specialty enzymes market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global specialty enzymes market vendors that include Advanced Enzyme Technologies, Amano Enzyme Inc., Amicogen Co. Ltd., Antozyme Biotech Pvt Ltd, BASF SE, BBI Solutions OEM Ltd., Codexis Inc., Creative Enzymes, DSM Firmenich AG, Enzyme Development Corp., Enzyme Supplies Ltd., F. Hoffmann La Roche Ltd., International Flavors Inc., Kerry Group Plc, Maravai LifeSciences Holdings, Nagase and Co. Ltd., Novonesis Group, Profacgen, Sanofi SA, Takara Bio Inc.. Also, the global specialty enzymes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Source
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Specialty Enzymes Market 2020 - 2024
  • Historic Market Size - Data Table on Global Specialty Enzymes Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.4 Source segment analysis 2020 - 2024
  • Historic Market Size - Source Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Specialty Enzymes Market
• 6.2 Impact of geopolitical conflict on Global Specialty Enzymes Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Research and biotechnology - Market size and forecast 2025-2030
• 8.4 Diagnostic - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by Type

• 9.1 Market segments
• 9.2 Comparison by Type
• 9.3 Carbohydrases - Market size and forecast 2025-2030
• 9.4 Proteases - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by Type
  • Market opportunity by Type ($ million)

10 Market Segmentation by Source

• 10.1 Market segments
• 10.2 Comparison by Source
• 10.3 Microorganisms - Market size and forecast 2025-2030
• 10.4 Plants - Market size and forecast 2025-2030
• 10.5 Animal - Market size and forecast 2025-2030
• 10.6 Market opportunity by Source
  • Market opportunity by Source ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Middle East and Africa - Market size and forecast 2025-2030
  • 12.6.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.2 UAE - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 Israel - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
• 12.7 South America - Market size and forecast 2025-2030
  • 12.7.1 Brazil - Market size and forecast 2025-2030
  • 12.7.2 Argentina - Market size and forecast 2025-2030
  • 12.7.3 Chile - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Expansion of precision medicine and advanced therapeutic modalities
  • Increasing integration of artificial intelligence in enzyme engineering
  • Rise of sustainable manufacturing and clean-label initiatives
• 13.2 Market challenges
  • High production complexity and capital requirements for customized enzymes
  • Stringent and fragmented global regulatory frameworks
  • Stability and logistical vulnerabilities in global distribution
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Shift toward enzyme-based precision diagnostics and personalized medicine
  • Revolutionization of enzyme discovery via generative artificial intelligence
  • Strategic portfolio realignment toward high-value life science segments

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Advanced Enzyme Technologies
  • Advanced Enzyme Technologies - Overview
  • Advanced Enzyme Technologies - Business segments
  • Advanced Enzyme Technologies - Key offerings
  • Advanced Enzyme Technologies - Segment focus
  • SWOT
• 15.5 Amano Enzyme Inc.
  • Amano Enzyme Inc. - Overview
  • Amano Enzyme Inc. - Product / Service
  • Amano Enzyme Inc. - Key offerings
  • SWOT
• 15.6 Amicogen Co. Ltd.
  • Amicogen Co. Ltd. - Overview
  • Amicogen Co. Ltd. - Product / Service
  • Amicogen Co. Ltd. - Key offerings
  • SWOT
• 15.7 BASF SE
  • BASF SE - Overview
  • BASF SE - Business segments
  • BASF SE - Key news
  • BASF SE - Key offerings
  • BASF SE - Segment focus
  • SWOT
• 15.8 BBI Solutions OEM Ltd.
  • BBI Solutions OEM Ltd. - Overview
  • BBI Solutions OEM Ltd. - Product / Service
  • BBI Solutions OEM Ltd. - Key offerings
  • SWOT
• 15.9 Creative Enzymes
  • Creative Enzymes - Overview
  • Creative Enzymes - Product / Service
  • Creative Enzymes - Key offerings
  • SWOT
• 15.10 DSM Firmenich AG
  • DSM Firmenich AG - Overview
  • DSM Firmenich AG - Business segments
  • DSM Firmenich AG - Key offerings
  • DSM Firmenich AG - Segment focus
  • SWOT
• 15.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.12 International Flavors Inc.
  • International Flavors Inc. - Overview
  • International Flavors Inc. - Business segments
  • International Flavors Inc. - Key news
  • International Flavors Inc. - Key offerings
  • International Flavors Inc. - Segment focus
  • SWOT
• 15.13 Kerry Group Plc
  • Kerry Group Plc - Overview
  • Kerry Group Plc - Business segments
  • Kerry Group Plc - Key news
  • Kerry Group Plc - Key offerings
  • Kerry Group Plc - Segment focus
  • SWOT
• 15.14 Maravai LifeSciences Holdings
  • Maravai LifeSciences Holdings - Overview
  • Maravai LifeSciences Holdings - Business segments
  • Maravai LifeSciences Holdings - Key offerings
  • Maravai LifeSciences Holdings - Segment focus
  • SWOT
• 15.15 Nagase and Co. Ltd.
  • Nagase and Co. Ltd. - Overview
  • Nagase and Co. Ltd. - Business segments
  • Nagase and Co. Ltd. - Key offerings
  • Nagase and Co. Ltd. - Segment focus
  • SWOT
• 15.16 Novonesis Group
  • Novonesis Group - Overview
  • Novonesis Group - Business segments
  • Novonesis Group - Key offerings
  • Novonesis Group - Segment focus
  • SWOT
• 15.17 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 15.18 Takara Bio Inc.
  • Takara Bio Inc. - Overview
  • Takara Bio Inc. - Product / Service
  • Takara Bio Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations